Loading clinical trials...

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema | Clinical Trials | Clareo Health

COMPLETEDPhase 3

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

A Double-blind, Randomized, Placebo-controlled, Cross-over Study to Evaluate the Clinical Efficacy and Safety of Subcutaneous Administration of Human Plasma-derived C1-esterase Inhibitor in the Prophylactic Treatment of Hereditary Angioedema

NCT01912456•CSL Behring

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Hereditary Angioedema Types I and II

Interventions

Low-volume C1-esterase inhibitor

Higher-volume C1-esterase inhibitor

+2 more

Locations

39

United States

Locations (39)

Study Site

Birmingham, Alabama, United States

Study Site

Scottsdale, Arizona, United States

Study Site

Bell Gardens, California, United States

Study Site

La Jolla, California, United States

Study Site

Orange, California, United States

Study Site

Walnut Creek, California, United States

Key Dates

Start Date

January 1, 2014

Primary Completion Date

October 1, 2015

Completion Date

October 1, 2015

Last Updated

January 29, 2021

Related Studies

Enrolling By InvitationPhase 2/3

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

NCT05396105

Hereditary AngioedemaHereditary Angioedema Type I+14 more

COMPLETEDPhase 3

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

NCT02316353

Hereditary Angioedema Types I and II

Sponsors

Lead Sponsor

CSL Behring

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2021Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions